- 2025-09-27 05:00NJK14047 1800576-41-3
- 2025-09-27 05:00Natsudaidain 35154-55-3
- 2025-09-27 05:00Murrayafoline A 4532-33-6
- 2025-09-27 05:00MKK7-COV-9 2283355-59-7
- 2025-09-27 05:00MK2-IN-5 (Hsp25 kinase inhibitor; Mk2 pseudosubstrate) 474713-20-7
- 2025-09-27 05:00Mitogen-activated protein kinase 1 (MAPK1) 137632-08-7
- 2025-09-27 05:00MBP MAPK Substrate 138028-00-9
- 2025-09-27 05:00Macranthoin G (Methyl 3,5-dicaffeoyl quinic acid) 159934-13-1
- 2025-09-27 05:00Klotho-derived peptide 1
- 2025-09-27 05:00KAI-11101
- 2025-09-27 05:00JNJ-49095397 (RV568) 1220626-82-3
- 2025-09-27 05:00JD123 696629-98-8
- 2025-09-27 04:59Iroxanadine sulfate ((-)-BRX 005 sulfate; (-)-BRX 235 sulfate) 276690-61-0
- 2025-09-27 04:59Iroxanadine hydrochloride 276690-59-6
- 2025-09-27 04:59Iroxanadine hydrobromide 276690-62-1
- 2025-09-27 04:59GDC-3280 1590403-33-0
- 2025-09-27 04:59Ganoderterpene A 2682180-85-2
- 2025-09-27 04:59EW-7195 1352609-28-9
- 2025-09-27 04:59Esculin sesquihydrate (esculin sesquihydrate) 66778-17-4
- 2025-09-27 04:59Emprumapimod hydrochloride (PF-07265803 hydrochloride)
